Norbert is a software developer in Germany. Master in computer science (Dipl.-Inform.). He enjoyed smoking for 30+ years. Became an accidental quitter in 2012, when curiosity lead to experimenting with vaping. The growing variety of flavours was pivotal for enjoying vaping more than smoking. Later joined the German vaping consumers organization IG-ED. Now a member of the board and liaison to INNCO and ETHRA.

Professor Marewa Glover has worked on reducing smoking-related harm for over 25 years. She has worked as a policy analyst, a co-ordinator of a national tobacco control programme, cessation trainer and, for over 17 years, as a researcher. She has chaired numerous committees and organisations including End Smoking NZ, an independent NGO that lobbied for a harm reduction approach even before electronic cigarettes were introduced. Marewa has over 100 publications reflecting her leadership and support of numerous studies. Her primary focus has been reducing smoking during pregnancy and reducing smoking among Māori, the indigenous people of New Zealand. She has also been a co-investigator on a number of innovative cessation projects and a longitudinal online survey of New Zealand vapers. Dr Glover is the most prominent public commentator on vaping in NZ. She is regularly called by the media and has appeared on NZ’s 60 Minutes in addition to participating in live online and conference debates about vaping. Despite an initial ban on the import and sale of nicotine for vaping imposed by the Ministry of Health, vaping has become established as a common and successful way to reduce or stop smoking in NZ. Marewa, along with a small number of other researchers who early on foresaw the potential of ecigs, have helped make this happen.

Professor Gerry Stimson is a leading advocate for tobacco harm reduction and an Emeritus Professor at Imperial College London. A public health social scientist, with over 50 years’ experience of research and advocacy, he was one of the founders of drugs harm reduction in the 1990s, helping to develop and evaluate harm reduction in the UK as a response to HIV/AIDS. Gerry has advised the UK Government, WHO, UNAIDS, UNODC, the World Bank and numerous governments around the world on issues relating to drugs, HIV infection and AIDS, and alcohol. He has also published over 220 scientific publications and several books. 

Currently, Gerry is Director of Research and Policy at Knowledge•Action•Change, and is involved in the FSFW-funded Global State of Tobacco Harm Reduction and Tobacco Harm Reduction Scholarship programmes. He is also a co-founder of the Global Forum on Nicotine, which has been delivered by KAC Communications since 2014. 

Peter Hajek is Professor of Clinical Psychology and Director of the Tobacco Dependence Research Unit at the Wolfson Institute of Preventive Medicine, Queen Mary University of London. His research is concerned primarily with understanding health behaviours, and developing and evaluating both behavioural and pharmacological treatments for dependent smokers and for people with weight problems. Professor Hajek is a member of a number of expert groups, advisory bodies and editorial boards, and has authored or co-authored over 350 publications.

Will Godfrey is the founding editor-in-chief of Filter (https://filtermag.org), an online magazine that launched in 2018 to cover drug use, drug policy and human rights through a harm reduction lens. He's also the executive director of The Influence Foundation, the nonprofit behind Filter. He previously founded The Influence, an award-winning drug policy news site, and ran Substance.com and the addiction-focused site The Fix. Before that, he co-founded an award-winning print publication for incarcerated people in London. He has consulted for numerous organisations in the drug policy and harm reduction space. He lives in New York.

Helen Redmond is an expert in substance use with over a decade of experience working with drug users and people with mental health problems. Her current focus is on helping smokers from vulnerable groups switch to e-cigarettes. At New York Harm Reduction Educators, Helen facilitates tobacco harm reduction/vaping groups. She is a senior editor at Filter and writes about vaping and creates short Op-Docs. Helen is adjunct faculty at the Silver School of Social Work at New York University.

Chim Ngoma is a passionate advocate for tobacco harm reduction and has led the THR Malawi project since 2018. He also works as an Assistant Manager on KAC’s THR Scholarship Programme. Chim has been involved in a number of notable THR projects and activities including the Burning Issues report and briefing paper on THR and the Right to Health as a reviewer. He also participated in a multi-stakeholder smoke-free dialogue in Cape Town aimed at informing the creation of the Smoke-Free Index, an initiative of the FSFW. Previously, Chim worked as a content writer consultant at Solimar International, as a citizen journalist at Nation Publications Limited and as a communications, visibility and M&E consultant at International Cooperation (GIZ).

Nancy Loucas is passionate about consumers having their voices heard in the narrative of THR and public health policy. Her consumer THR journey began in 2015 as one of the founders/co directors of Aotearoa Vapers Community Advocacy (AVCA) in New Zealand, doing battle for the rights of vapers to be able to access what they need to become/remain smoke free.

Nancy participated in developing INNCO from its inception (2016) and served as first president of the Governing Board in 2017-2018.

Nancy is currently the founder and Executive Coordinator for CAPHRA - the Coalition of Asia Pacific Tobacco Harm Reduction Advocates. CAPHRA supports consumer THR advocacy organisations and activities throughout the Asia Pacific region and has developed and presented various programmes for consumers such as the Voices4Vape online seminar series, the Right2Switch global consumer petition and, with CASAA in the US, the RightToVape.org Testimonial database that contains thousands of consumer testimonials globally.

Nancy is also the founder and director of Paraclete Associates Limited, (PAL), providing guidance on THR policy, regulation and programme development/advocacy mentoring globally. PAL was instrumental in the development and coordination of the sCOPe 5-day livestream that ran during the FCTC COP 9 in 2021. PAL also produces the consumer THR news show “The Advocates Voice.”

Professor Marewa Glover has worked on reducing smoking-related harm for over 25 years. She has worked as a policy analyst, a co-ordinator of a national tobacco control programme, cessation trainer and, for over 17 years, as a researcher. She has chaired numerous committees and organisations including End Smoking NZ, an independent NGO that lobbied for a harm reduction approach even before electronic cigarettes were introduced. Marewa has over 100 publications reflecting her leadership and support of numerous studies. Her primary focus has been reducing smoking during pregnancy and reducing smoking among Māori, the indigenous people of New Zealand. She has also been a co-investigator on a number of innovative cessation projects and a longitudinal online survey of New Zealand vapers. Dr Glover is the most prominent public commentator on vaping in NZ. She is regularly called by the media and has appeared on NZ’s 60 Minutes in addition to participating in live online and conference debates about vaping. Despite an initial ban on the import and sale of nicotine for vaping imposed by the Ministry of Health, vaping has become established as a common and successful way to reduce or stop smoking in NZ. Marewa, along with a small number of other researchers who early on foresaw the potential of ecigs, have helped make this happen.

Konstantinos Farsalinos, MD, MPH is a physician and senior researcher at the University of Patras and the School of Public Health-University of West Attica in Greece. His field of expertise is Public Health. He has been conducting laboratory, clinical and epidemiological research on smoking, tobacco harm reduction and e-cigarettes as principal investigator since 2011. He authored the first systematic review on e-cigarette safety/risk profile, published in 2014. Additionally, he has performed research and published studies on heated tobacco products. His findings have been presented in major international scientific congresses and his studies were used in preparing the regulatory framework on e-cigarettes by the European Union. As of mid-2020, he has published more than 90 studies and articles in international peer-reviewed scientific journals about smoking, tobacco harm reduction and alternative-to-smoking nicotine products. He was the handling editor and author of a book titled "Analytical assessment of e-cigarettes", published by Elsevier in 2017. In November 2020, he was declared a Highly Cited Researcher 2019 by the Web of Science, a list of researchers (6200 scientists out of 9 million examined) with the highest impact in global science in 21 scientific fields in the past decade. During the COVID-19 pandemic, he has published 6 peer-reviewed studies and several pre-prints about the COVID-19, including the association between smoking, nicotine and COVID-19.

Dr Roberto A Sussman is a full time senior researcher and lecturer in physics at the National University of Mexico. He specializes in Theoretical Cosmology but has undertaken research and frequent peer reviewing for journals in other areas of Astrophysics. He is also the founder and Director of Pro-Vapeo Mexico, an association representing Mexican consumers of noncombustible nicotine products and is a member of INNCO. He is actively advocating for an appropriate regulation of Tobacco Harm Reduction products in Mexico. He directs and supervises the effort to spread scientific information on these products, as well as advising consumers on how to counter the misinformation and prejudice about them that is rampant throughout Latin America.

Kevin McGirr is Clinical Professor in the School of Nursing; has taught in schools of medicine, social work and public health and was a Fulbright Scholar in Pondicherry India, 2013-2014.  He has over forty years experience in providing and managing behavioral health services; holds master’s degrees in public health, psychiatric nursing and ABD in public health. He has been involved in the training and development of harm reduction services and in particular utilizing Harm Reduction Tobacco interventions for persons with serious mental illness.

Professor Marewa Glover has worked on reducing smoking-related harm for over 25 years. She has worked as a policy analyst, a co-ordinator of a national tobacco control programme, cessation trainer and, for over 17 years, as a researcher. She has chaired numerous committees and organisations including End Smoking NZ, an independent NGO that lobbied for a harm reduction approach even before electronic cigarettes were introduced. Marewa has over 100 publications reflecting her leadership and support of numerous studies. Her primary focus has been reducing smoking during pregnancy and reducing smoking among Māori, the indigenous people of New Zealand. She has also been a co-investigator on a number of innovative cessation projects and a longitudinal online survey of New Zealand vapers. Dr Glover is the most prominent public commentator on vaping in NZ. She is regularly called by the media and has appeared on NZ’s 60 Minutes in addition to participating in live online and conference debates about vaping. Despite an initial ban on the import and sale of nicotine for vaping imposed by the Ministry of Health, vaping has become established as a common and successful way to reduce or stop smoking in NZ. Marewa, along with a small number of other researchers who early on foresaw the potential of ecigs, have helped make this happen.

Dr Brad Rodu is a professor of medicine and holds an endowed chair in tobacco harm reduction research at the University of Louisville, Kentucky USA. Since 1994 Rodu has authored 70 medical publications about tobacco, and he blogs at Rodu Tobacco Truth (http://rodutobaccotruth.blogspot.com/).

Riccardo Polosa is the Founder of the Center of Excellence for the acceleration of HArm Reduction (CoEHAR - University of Catania, Italy). Dr Polosa is Full Professor of Internal Medicine for the same University and Director of the Center for Smoking Prevention and Treatment at the University Hospital "Policlinico-V. Emanuele” of Catania. Dr. Polosa and the CoEHAR team of researchers conduct several high-profile clinical and behavioral research in the field of smoking-related diseases. According to a bibliometric analysis, Professor Polosa is considered the most productive scientist in the world in the field of electronic cigarette research.